Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Supply of DEA-Regulated Veterinary Euthanasia Drug

Active

Federal

Response Deadline08/05/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the manufacture and delivery of Pentobarbital Sodium Injection, marketed as Veterinary Fatal Plus, in 250ml vials, strictly adhering to FDA current Good Manufacturing Practices and DEA Schedule C-II regulations for controlled substances. The product is intended for veterinary euthanasia use and must meet all applicable federal standards for potency, purity, labeling, security, and documentation required for Schedule II controlled substances. Production and packaging must ensure traceability, tamper resistance, and compliance with DEA inventory and reporting protocols to prevent diversion or misuse. The solicitation, issued by the Department of Defense under the Medical Supply Chain Pharm FSA, is a subcontract with a performance location at Lackland AFB, Texas, zip code 78236-5638. It was posted on July 30, 2026, with responses due by August 5, 2026. The NAICS code 325412 identifies the industry as pharmaceutical preparations manufacturing. Bidders must demonstrate proven capability in handling regulated veterinary pharmaceuticals, secure supply chain practices, and compliance with federal controlled substance laws. No set-aside provisions are specified, indicating this opportunity is open to all qualified contractors without preference based on size or status.

General Info

Manufacture and deliver FDA-compliant Veterinary Fatal Plus in 250ml vials per DEA Schedule II requirements for DoD at Lackland AFB.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

LACKLAND AFB, TX, 78236-5638, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 30

subcontract

Response DeadlineAug 5

Submission deadline

Response Deadline

08/05/2026, 05:00:00 PM UTCin 4 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacture and delivery of Pentobarbital Sodium Injection (Veterinary Fatal Plus), 250ml vials, compliant with FDA cGMP and DEA Schedule C-II requirements for controlled substances.

Similar Contracts

Same NAICS industry code

Flu Vaccines and Associated Supplies

Solicitation # HM047626Q0030

The solicitation for Flu Vaccines and Associated Supplies under HM047626Q0030 has been amended to remove the clause 52.219-6 NOTICE OF TOTAL SMALL BUSINESS SET-ASIDE, indicating the procurement is no longer restricted to small businesses. The government has also provided responses to questions received from potential offerors, with the full Q&A attached for reference. The deadline for submitting proposals has been extended to 5:00 p.m. Central Time on August 10, 2026, and all proposal submission requirements have been updated accordingly to reflect this new date. All other terms and conditions of the original solicitation remain in effect. The award will be made to the responsible offeror submitting the lowest price technically acceptable quote, as determined by the LPTA evaluation method. Offerors must review the full solicitation document and Statement of Work, and submit a completed quote sheet as required. The contracting activity is managed by the National Geospatial-Intelligence Agency under the Department of Defense, with the primary point of contact being Kathleen Dee at the provided email and phone number. The place of performance is in Springfield, Virginia, while the issuing office is located in Arnold, Missouri.

National Geospatial-Intelligence Agency

POSTED

about 23 hours ago

DEADLINE

Supply of Vitamin and Mineral Fortified BlendsThe contract pertains to the production and supply of micronutrient-fortified nutritional blends designed to combat vitamin and mineral deficiencies within clinical environments. These products are intended for use in healthcare settings to support patient recovery and nutritional adequacy, particularly in populations at risk of deficiencies. The work is classified under NAICS code 325412, indicating manufacturing of pharmaceutical and botanical products, and is structured as a subcontract, suggesting it is part of a larger procurement effort led by the South East Regional Health Authority under the Government of Jamaica. The solicitation was posted on July 30, 2026, and performance is expected to occur within Jamaica, though specific location details are not provided. The contract does not specify a set-aside designation or point of contact, indicating that further details may be obtained through the provided government portal link.

South East Regional Health Authority

POSTED

DEADLINE

Pharmaceutical Manufacturing – Tolnaftate Powder (USP 1%)The contract calls for the manufacture of Tolnaftate Powder, USP 1%, in 45-gram units, adhering strictly to United States Pharmacopeia standards, Good Manufacturing Practices, and applicable military specifications. Production must include comprehensive batch testing and rigorous quality control measures to ensure consistency, purity, and potency throughout the manufacturing process. All units must meet exacting pharmaceutical and defense-grade requirements, with full traceability and documentation to support regulatory compliance and operational readiness. The solicitation is classified as a subcontract under NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as FPO with ZIP code 09570, indicating delivery to a military postal address. The response deadline is August 5, 2026, with the solicitation posted on July 30, 2026, leaving a limited window for qualified manufacturers to submit proposals. While no specific set-aside status or point of contact is provided, interested parties must reference the official DIBBS portal link to access full solicitation details and ensure compliance with all submission requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dental Bonding Agent SupplyThe contract involves the supply and delivery of a commercial off-the-shelf dental bonding agent known as the Ultra-Etch 4PK Kit, which includes viscous 35% phosphoric acid gel, syringes, and micro tips, all packaged and labeled to meet federal and military compliance standards. The product must be shipped in accordance with strict regulatory requirements to ensure safety, efficacy, and readiness for use in military medical environments. The solicitation is issued under the NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and is managed by the Department of Defense through the Medical Supply Chain FSH. The place of performance is specified as Suffolk, Virginia, with a zip code of 23435-5000, indicating where the delivered goods will be received and utilized. The solicitation was posted on July 30, 2026, with a response deadline of August 6, 2026, giving potential suppliers just one week to submit their proposals. This is structured as a subcontract opportunity, meaning it is likely part of a larger procurement effort, and no specific set-aside classification has been designated, indicating it is open to all eligible contractors regardless of business size or category. The contract is accessible via the DIBBS platform, which is the Department of Defense’s official system for managing procurement actions, and all submissions must comply with the technical, logistical, and regulatory demands outlined to ensure seamless integration into military dental care protocols.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Dental Calcium Hydroxide Paste Manufacturing & SupplyThe contract calls for the manufacture and supply of a radiopaque, antibacterial calcium hydroxide paste specifically designed for dental endodontic applications, with strict adherence to FDA and DLA specifications. The scope encompasses the full lifecycle of the product including formulation development, packaging, labeling, and compliance with safety data sheet requirements to ensure regulatory and clinical suitability. The product must meet precise technical standards to function effectively in root canal treatments, combining radiopacity for accurate imaging with antibacterial properties to inhibit microbial growth. Performance is designated to occur in Suffolk, Virginia, with a response deadline of August 6, 2026, and the solicitation is classified as a subcontract under NAICS code 325412 for pharmaceutical and cosmetic manufacturing. The contracting organization is the Department of Defense through its Medical Supply Chain FSH unit, indicating this is a defense-related procurement aimed at equipping military dental services. All materials and processes must align with federal procurement and quality control mandates, and submission is managed through the DLA’s DIBBS platform.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Supplier – BenzoCaine and Menthol LozengesThe contract calls for the supply of six units of CHLORASEPTIC MAX lozenges, each containing 15 mg of benzocaine and 10 mg of menthol, to meet stringent FDA, OSHA, and Department of Defense packaging and labeling requirements. The deliverables must comply with all regulatory standards for pharmaceutical products intended for military and federal use, ensuring safe handling, accurate identification, and proper storage conditions. The solicitation is classified as a subcontract under NAICS code 325412, indicating it falls within the pharmaceutical and medicine manufacturing sector, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a limited window for potential suppliers to prepare and submit proposals. The place of performance is designated as Ellsworth Air Force Base, South Dakota, with a zip code of 57706-4821, indicating the final destination for the lozenges. Although the solicitation number and point of contact details are not provided in the data, the official record is accessible through the DIBBS platform at the specified URL. All parties must adhere to DoD procurement protocols, including documentation, quality assurance, and delivery timelines to meet operational readiness needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Dextrose Injection 5% (NSN 6505013306252)The contract requires the supply and delivery of Dextrose Injection 5%, USP, 1000 mL, in 12-unit cases, in full compliance with U.S. Pharmacopeial standards and the Defense Logistics Agency’s technical specifications. The product, identified by NSN 6505013306252, is intended for federal medical use and must meet stringent quality, packaging, and labeling requirements to ensure safety and efficacy. Performance is to be executed at the FPO mail facility with ZIP code 96669, reflecting the logistical nature of military medical supply distribution. The solicitation, issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, is structured as a subcontract opportunity managed by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a seven-day window for interested vendors to submit proposals through the DIBBS platform.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supplier – Lidocaine Hydrochloride and Epinephrine InjectionThe contract involves the supply of Lidocaine Hydrochloride and Epinephrine Injection in predetermined packaging units, requiring full compliance with FDA regulations, United States Pharmacopeia standards, and military-specific packaging requirements. The product must be manufactured and packaged to meet the strict quality and safety benchmarks set by these authorities to ensure suitability for use in military and defense medical applications. All deliveries are to be fulfilled to the specified place of performance, identified as FPO with ZIP code 96691, indicating delivery to a U.S. military postal address. Subcontractors responding to this solicitation must submit proposals by the deadline of August 5, 2026, following the NAICS code 325412 for pharmaceutical preparation manufacturing. The agency managing the requirement is the Department of Defense, specifically under the Medical Supply Chain Pharm FSA, which oversees the procurement of critical medical pharmaceuticals for military use. The contract is classified as a subcontract and is posted on the DIBBS system, where interested parties can access the official solicitation details through the provided link. There is no set-aside designation, meaning all eligible vendors may compete without restriction based on business size or socioeconomic status.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isopropyl Alcohol Supply and PackagingThe contract involves the supply, repackaging, labeling, and delivery of USP-grade Isopropyl Alcohol at 99% concentration in 473 mL bottles, requiring full compliance with hazardous material transportation regulations and Department of Defense packaging standards. All activities must ensure the product meets stringent quality and safety requirements for use in medical and defense applications, with packaging designed to withstand transport and storage under military conditions. The work is to be performed at a designated location in Tampa, Florida, with a zip code of 33621. This is a subcontract opportunity issued under NAICS code 325412, which pertains to pharmaceutical and medicinal chemical manufacturing. The solicitation was posted on July 30, 2026, with a response deadline of August 5, 2026. The issuing organization is the Medical Supply Chain Pharm FSA within the Department of Defense, indicating the product is destined for federal medical or operational use. Bidders must be prepared to meet exacting logistics and labeling protocols to ensure seamless integration into DoD supply chains, and all submissions must be completed by the specified deadline for consideration.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-26-T-4389

The contract specifies the procurement of bupivacaine and epinephrine injection in 1.8 mL cartridges containing 0.500% w/v bupivacaine hydrochloride and 0.005 mg epinephrine per mL (1:200,000), supplied in lots of 50 cartridges per container, with a total quantity of two containers. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and maintain a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be commercially packaged to ensure protection from damage and safe transport via common carrier at lowest cost to the destination. The material is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though all DLA Technical and Quality Requirements take precedence. Mercury or mercury-containing compounds are prohibited in direct contact with the product, except for functional uses in batteries, instruments, or sensors as permitted under NAVSEA guidelines. Delivery is required FOB destination within 20 days of order placement to the USS MIGUEL KEITH (ESB-5) in San Diego, California, with no tolerance for quantity variance. The item is identified by NSN 6505-01-189-3973 and referenced under Purchase Request 7017681406, with multiple approved manufacturers listed including DENTAL HEALTH PRODUCTS INCORPORATED, CARESTREAM DENTAL LLC, PATTERSON DENTAL, HENRY SCHEIN, INC., and BENCO DENTAL SUPPLY CO. All packaging and labeling must adhere to DLA Packaging Requirements for Procurement and palletization standards, and shipment details include vessel-specific transport instructions and government-only tracking identifiers.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CARPROFEN TABLETS

Solicitation # SPE2DP-26-T-4392

Carprofen Tablets 100mg are chewable nonsteroidal anti-inflammatory, analgesic, and antipyretic tablets specifically formulated for dogs, supplied in bottles of 60 tablets each. The product is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including packaging standards per Medical Marking Standard No. 1 and MIL-STD-2073-1E, with no tolerance for quantity variance. It is classified as a Type I (Code Q) item with a fixed 36-month shelf life that is non-extendable and must be stored at controlled room temperature between 15–30°C (59–86°F). The item is procured under solicitation SPE2DP-26-T-4392 with a delivery requirement of 20 days FOB destination, and inspection and acceptance occur at the delivery point. Only approved manufacturers including Zoetis Inc., Covetrus North America, LLC, and Patterson Veterinary Supply, Inc. with specified part numbers are eligible, and all supplies must be properly marked in accordance with government standards. The contracting official must submit a referral through EBS to confirm product suitability before award, and the item is identified by NSN 6509014874464 under the Department of Defense’s Medical Supply Chain PHARM FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PENTOBARBITAL SODIU

Solicitation # SPE2DP-26-T-4387

Pentobarbital Sodium Injection, Veterinary, is a Schedule II controlled substance with high abuse potential, supplied in 250ml vials containing 6 grains of sodium pentobarbital for euthanasia purposes. Each unit is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months and must be stored under vault conditions at room temperature in compliance with DEA regulations for Schedule II drugs. The product is regulated by the FDA and must be labeled and accompanied by Safety Data Sheets (SDS) aligned with OSHA’s Hazard Communication Standard and the Globally Harmonized System, effective after June 1, 2015. Labeling and documentation must conform to 29 C.F.R. 1910.1200, and suppliers are required to train employees on these requirements. All packaging must adhere to MIL-STD-2073-1E and the latest Medical Marking Standard No. 1, with government identification removed from non-accepted supplies per RQ011. The contract, issued under solicitation SPE2DP-26-T-4387, specifies a quantity of two units, each costing $2.00, for a total price of $4.00, with delivery required within five days FOB destination. Inspection and acceptance occur at the delivery point, with zero tolerance for quantity variance. The NSN is 6509-01-485-6206, and the item is procured under the DOD’s authorized unit of issue. The point of contact for the procurement is Shairy M. Cartagena of the Department of Defense’s Medical Supply Chain PHARM FSA, with performance taking place at Lackland AFB. The product is supplied by Patterson Veterinary Supply, Inc. and Covetrus North America, LLC, identified by respective part numbers, and the acquisition falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

OMEPRAZOLE EXTENDED-RE

Solicitation # SPE2DP-26-T-4251

OMEPRAZOLE EXTENDED-RELEASE CAPSULES, 20 MG DELAYED RELEASE, in 90-count bottles, are being procured under solicitation SPE2DP-26-T-4251 by the Department of Defense’s Medical Supply Chain Pharm FSA. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, which take precedence over all other packaging standards. Each unit is defined by the unit of issue “BT,” representing 90 capsules per bottle, with all deliveries required to have at least 21 months of remaining shelf life out of a 24-month total shelf life, non-extendable. Packaging must protect against damage and be commercially sealed, with exterior shipping containers suitable for safe transport via common carrier at lowest cost. Palletization must adhere to RP001 DLA Packaging Requirements, and all labeling and marking must follow MIL-STD-129 as the governing standard, superseding references to MIL-STD-129. Markings must include Unit of Issue, Quantity per Unit Pack, freight and mark-for addresses, and traceable identifiers. Parcel post is explicitly prohibited, and shipments must be sent via the fastest traceable means. All items are to be delivered FOB destination within five days of award, with delivery points at Fort Stewart, GA, and Fort Campbell, KY. The contract includes five CLINs totaling 15 BT (1,350 capsules), with no variance allowed in quantity. The drug is supplied by Sandoz Inc., with NDC 00781-2868-92. Technical compliance is enforced through the DLA Master List, which governs all quality and packaging specifications. The product is non-hazardous under FED-STD-313 and must conform to ASTM D3951 for commercial packaging, unless a deviation applies, in which case TQ IP025 governs. All contractors must comply with FAR/DFARS clauses requiring cybersecurity protections under 252.204-7012 and NIST SP 800-171, safeguarding covered defense information and reporting cyber incidents. Contractors must also adhere to whistleblower protections, trafficking in persons prohibitions, employment verification requirements, and sustainable product preferences. Proposal submissions are exclusively through the DLA Internet Bid Board System (DIBBS) by the deadline of July 29, 20

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

IOHEXOL INJECTION

Solicitation # SPE2DP-26-T-4252

IOHEXOL INJECTION, USP, 300MG per mL in 150 mL polymer bottles, packaged in units of 10 bottles per box, is being procured under solicitation SPE2DP-26-T-4252 for delivery to Fort Bragg, North Carolina. The contract specifies a quantity of 24 boxes with a required delivery within five days after the delivery order is issued, and the original required delivery date is July 24, 2026. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 20–25°C (68–77°F), with permissible excursions to 15–30°C (59–86°F), protected from strong daylight and direct sunlight, and must not be frozen. Packaging must comply with Commercial standards and the DLA Master List of Technical and Quality Requirements, superseding ASTM D3951 where applicable. All packaging and marking must adhere to Medical Marking Standard No. 1, replacing MIL-STD-129, and include permanent, legible labeling with the correct unit of issue, quantity per unit pack, and barcoding per current specifications. As a hazardous material under OSHA’s Hazard Communication Standard, the product must be accompanied by Safety Data Sheets compliant with 29 CFR 1910.1200 and labeled according to the Globally Harmonized System. Suppliers must submit both SDS and HCS-compliant labels for approval prior to award and must train employees on these requirements. Palletization must meet DLA Packaging Requirements for Procurement (RP001), and shipment must be made by the fastest traceable means, excluding parcel post. The delivery is FOB destination, with inspection and acceptance occurring at the delivery point. The contract incorporates numerous Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses, including requirements for equal opportunity, combating human trafficking, employment eligibility verification, sustainable products, hazardous material identification, cybersecurity safeguards for covered defense information, whistleblower protections, and prohibitions on certain telecommunications equipment and toxic substances. The contractor must maintain current registration in the System for Award Management and submit invoices exclusively via the Wide Area WorkFlow portal using the appropriate document types. No contract value or unit price is provided in the document, and no evaluation factors, award basis, or past performance criteria are specified. All representations and

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

Hazardous Materials Handling and Transportation LogisticsThe contract involves the safe and compliant transportation of hazardous materials under the rigorous standards of DOT HAZMAT regulations under 49 CFR 172, DLA shipping protocols, and applicable commercial container requirements. All work must be performed by certified carriers with the necessary credentials and operational protocols to handle dangerous goods, ensuring zero deviations from federal and departmental safety guidelines. The scope is centered on logistics coordination for the Medical Supply Chain Pharm FSA under the Department of Defense, requiring precise adherence to documentation, labeling, packaging, and transport procedures for hazardous pharmaceutical and medical supplies. Performance is to be conducted with a place of performance listed as FPO 96675, indicating operations may involve overseas or military logistics networks. The solicitation is structured as a subcontract with a response deadline of August 5, 2026, and falls under NAICS code 484220 for hazardous materials transportation. The contract demands full compliance with all regulatory and procedural obligations without exception, and any failure to meet these standards could result in non-performance penalties or contract termination. There is no set-aside designation, meaning all qualified entities may compete, and the focus remains on reliability, regulatory integrity, and timely delivery of critical defense-related hazardous materials.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Military Packaging and Marking ServicesThe contract solicits subcontractor services for the packaging and marking of both hazardous and non-hazardous materials in full compliance with MIL-STD-129, FED-STD-313, and Defense Logistics Agency procurement standards. Work includes precise palletization and export-ready containerization to ensure materials meet military logistics and international shipment requirements. All activities must adhere to strict federal and defense-specific guidelines to maintain readiness and regulatory compliance across the supply chain. The opportunity is posted under NAICS code 322291 and is classified as a subcontract, with a response deadline of August 5, 2026. Performance will be conducted at FPO 96675, with the contracting entity operating under the Department of Defense and specifically managed by the Medical Supply Chain Pharm FSA. The solicitation does not specify a set-aside type and is accessible through the DIBBS platform for qualified subcontractors seeking to support defense logistics operations.

Sanitary Paper Product Manufacturing

POSTED

DEADLINE

Safety Data Sheets (SDS) Management and ComplianceThe contract requires the preparation, maintenance, and timely updating of Safety Data Sheets for all hazardous materials used within the scope of operations, with strict adherence to the Globally Harmonized System of Classification and Labeling of Chemicals, Occupational Safety and Health Administration regulations, and additional contractual obligations. All SDS documentation must be accurate, current, and fully compliant with federal safety standards to ensure the protection of personnel and the environment, as well as to meet the demanding requirements of the Department of Defense’s Medical Supply Chain. Performance is tied to the Federal Supply Activity under the Department of Defense, with work to be performed at FPO, ZIP 96675, and submitted under a subcontract arrangement. The solicitation, identified by the NAICS code 541690 for other scientific and technical consulting services, was posted on July 30, 2026, with responses due by August 5, 2026. Contractors must be prepared to demonstrate full regulatory knowledge and operational capability to manage SDS systems reliably and proactively, ensuring continuous compliance across all hazardous material handling and storage activities.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Hazardous Materials Labeling and Compliance ServicesThis contract requires the application and verification of hazard warning labels that comply with OSHA HazCom standards under 29 CFR 1910.1200 and MIL-STD-129 military marking requirements. The work involves ensuring all hazardous materials are properly labeled to meet federal safety and identification regulations, with emphasis on consistency, accuracy, and compliance across military and industrial supply chains. Performance is expected at an FPO location with ZIP code 96675, indicating operations may involve overseas or maritime logistics environments where standardized labeling is critical for safety and regulatory adherence. The contract is classified as a subcontract under NAICS code 541380, which pertains to other scientific and technical consulting services, and is solicited by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 30, 2026, with a response deadline of August 5, 2026, indicating a tight turnaround for proposers to demonstrate capability in hazardous materials labeling, quality control, and familiarity with both civilian and military compliance frameworks. Failure to meet labeling standards could result in safety risks or rejection of materiel, making technical expertise and adherence to exact specifications essential for successful contract execution.

Testing Laboratories and Services

POSTED

DEADLINE

Small Business Subcontracting Support (Administrative)The contract seeks administrative support to ensure compliance with subcontracting requirements under DFARS 52.244-6 for commercial subcontracts, focusing on small business outreach and comprehensive recordkeeping. The work involves facilitating the identification, engagement, and documentation of small business subcontractors to meet federal compliance standards, requiring meticulous tracking of subcontracting efforts and accurate maintenance of related records throughout the contract period. The task is administrative in nature and must align with Department of Defense procurement guidelines. The solicitation is open to vendors responding by August 5, 2026, under NAICS code 541611, which pertains to management consulting services. Performance will be conducted at a military postal address in FPO with zip code 09570, indicating overseas or mobile operations support. The contracting activity is managed by the Medical Supply Chain Pharm FSA within the Department of Defense, and while no specific set-aside designation is listed, the emphasis on small business outreach suggests a strong preference for participation by small businesses in the subcontracting process. Proposals must demonstrate capability in navigating federal subcontracting regulations and delivering compliant administrative support under tight timelines.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Cybersecurity Compliance for Covered Defense Information (CDI)This contract requires the implementation of NIST Special Publication 800-171 controls to protect covered defense information as mandated by DFARS 252.204-7012, ensuring that all systems handling such information meet rigorous cybersecurity standards. The subcontractor must establish and maintain appropriate technical, administrative, and physical safeguards to prevent unauthorized access, disclosure, or loss of sensitive data, while also establishing procedures for timely cyber incident reporting in accordance with federal requirements. Compliance is non-negotiable and must be fully operational prior to any handling of covered defense information under this agreement. The work is classified as a subcontract under the NAICS code 541512, associated with the Department of Defense’s Medical Supply Chain Pharm FSA, with performance to occur at the FPO address with ZIP code 09570. Proposals must be submitted by the deadline of August 5, 2026, and the contract is not subject to any specific set-aside provisions. While the point of contact details are not provided, all responses must align with the technical and regulatory expectations outlined in the DFARS clause and NIST framework, with failure to comply potentially resulting in termination or liability. The solicitation is accessible through the specified DIBBS link for further submission details.

Computer Systems Design Services

POSTED

DEADLINE

Defense Logistics Transportation and FOB Destination DeliveryThe contract requires the transportation of packaged pharmaceuticals to Tinker AFB, Nellis AFB, and FPO addresses using traceable, non-parcel post freight methods under FOB destination terms, ensuring delivery responsibility and risk transfer occur only upon arrival at the final destination. All shipments must maintain full traceability throughout the supply chain and comply with strict logistical standards for sensitive medical materials, with performance centered on secure, timely delivery to designated military locations. The NAICS code 484220 indicates this is a contract for freight transportation by truck, and the solicitation is classified as a subcontract under the Department of Defense’s Medical Supply Chain PHARM FSA. The solicitation was posted on July 30, 2026, with responses due by August 5, 2026, providing a limited window for qualified carriers to submit proposals. Performance is primarily directed toward FPO addresses with a zip code of 09570, indicating a focus on overseas military postal destinations, alongside U.S.-based Air Force installations. The terms emphasize accountability and compliance without the use of standard parcel post services, necessitating specialized freight solutions that meet Department of Defense supply chain security protocols. No set-aside information or point of contact details are provided, and the contract is accessible through the DIBBS portal for eligible subcontractors.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Hazardous Materials Handling and Safety Data Sheet (SDS) PreparationThe contract involves the preparation and submission of Safety Data Sheets for hazardous pharmaceutical materials, ensuring full compliance with OSHA’s 29 CFR 1910.1200(g) regulations. This subcontract requires accurate documentation that accurately reflects the chemical composition, physical and health hazards, handling procedures, emergency measures, and regulatory information for each hazardous pharmaceutical product. Compliance with federal safety standards is mandatory, and all SDSs must be structured and formatted according to the Globally Harmonized System of Classification and Labelling of Chemicals as adopted by OSHA. The work must be completed within the specified timeframe and delivered in a manner that meets the Department of Defense’s requirements for accuracy, clarity, and accessibility. The solicitation is issued under the NAICS code 541690 for other scientific and technical consulting services and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. The place of performance is designated as FPO with a zip code of 09570, indicating potential operations or deliveries to military postal locations. Responses are due by August 5, 2026, and the contract was posted on July 30, 2026, offering a limited window for interested parties to submit proposals. This procurement is not subject to any specific set-aside designation, meaning it is open to all qualified subcontractors regardless of business size or status, and the winning party will be responsible for delivering SDS documentation that supports safe handling and transport of hazardous pharmaceuticals within the defense supply chain.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Military-Compliant Packaging and LabelingThe contract requires full compliance with military and federal standards for the packaging and labeling of Tolnaftate Powder, specifically adhering to MIL-STD-129 for marking and labeling, ASTM D3951 for protective packaging, and OSHA 29 CFR 1910.1200 for hazardous material communication, including proper hazard signage, safety data sheet alignment, and container labeling. All materials must be palletized in accordance with military logistics requirements to ensure safe transport, storage, and inventory handling within the Department of Defense supply chain. The work must be executed to meet exacting durability, identifiability, and safety standards for use in operational environments. This subcontract, issued under NAICS code 323111, is solicited by the Medical Supply Chain Pharm FSA under the Department of Defense and has a response deadline of August 5, 2026. Performance is to be conducted at FPO, zip code 09570, and the solicitation is accessible through the DIBBS platform. The requirement is set as a general subcontract without specific set-aside designations, and all proposals must demonstrate rigorous adherence to the cited standards and readiness to support military medical supply operations with certified, audit-ready packaging conforming to federal defense logistics protocols.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE